The Use of Cylexin (CY-1503) in Prevention of Reperfusion Lung Injury in Patients Undergoing Pulmonary Thromboendarterectomy

MLA

Kim M. Kerr, et al. “The Use of Cylexin (CY-1503) in Prevention of Reperfusion Lung Injury in Patients Undergoing Pulmonary Thromboendarterectomy.” American Journal of Respiratory and Critical Care Medicine, vol. 162, July 2000, pp. 14–20. EBSCOhost, https://doi.org/10.1164/ajrccm.162.1.9712142.

APA

Kim M. Kerr, Kenneth M. Moser, Gerard J. Smits, Stuart W. Jamieson, David P. Kapelanski, James J. Marsh, Rebekah L. Fedullo, Peter F. Fedullo, Richard N. Channick, Roberta M. Comito, & William R. Auger. (2000). The Use of Cylexin (CY-1503) in Prevention of Reperfusion Lung Injury in Patients Undergoing Pulmonary Thromboendarterectomy. American Journal of Respiratory and Critical Care Medicine, 162, 14–20. https://doi.org/10.1164/ajrccm.162.1.9712142

Chicago

Kim M. Kerr, Kenneth M. Moser, Gerard J. Smits, Stuart W. Jamieson, David P. Kapelanski, James J. Marsh, Rebekah L. Fedullo, et al. 2000. “The Use of Cylexin (CY-1503) in Prevention of Reperfusion Lung Injury in Patients Undergoing Pulmonary Thromboendarterectomy.” American Journal of Respiratory and Critical Care Medicine 162 (July): 14–20. doi:10.1164/ajrccm.162.1.9712142.